Medicare Enrolled
Dr. Daniel Saltzstein, MD
Surgery · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Saltzstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saltzstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Saltzstein
Dr. Daniel Saltzstein is a surgery specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Saltzstein performed 19,766 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Saltzstein received a total of $597,616 from 50 pharmaceutical and/or device companies across 761 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Saltzstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in TX
$597,616 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗19,766
Medicare services
Top 0% in TX for surgery
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 10,320 | $18 | $31 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
1,608 | $34 | $78 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,260 | $3 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,062 | $87 | $215 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
900 | $7 | $95 |
| PSA test (prostate cancer screening) | 864 | $18 | $110 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
787 | $40 | $80 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
501 | $25 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $57 | $150 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
198 | $8 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
152 | $8 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 150 | $131 | $700 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
145 | $6 | $25 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
133 | $34 | $78 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
133 | $34 | $78 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
132 | $34 | $78 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
124 | $178 | $490 |
| Liver function blood test panel | 107 | $8 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $116 | $313 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
91 | $10 | $30 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
91 | $23 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
57 | $78 | $210 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
56 | $36 | $90 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
50 | $2 | $8 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
50 | $2 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
38 | $8 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $127 | $290 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
37 | $18 | $150 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
37 | $20 | $115 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
32 | $97 | $275 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
27 | $5 | $20 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
27 | $4 | $20 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
25 | $229 | $700 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
25 | $29 | $210 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $50 | $215 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $312 | $2,000 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
15 | $125 | $685 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
14 | $43 | $180 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $90 | $1,286 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
13 | $33 | $92 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
12 | $97 | $350 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
12 | $25 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
58.0% medium
41.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$597,616
Total received (2018-2024)
Avg $85,374/year across 7 years
Top 0% in TX for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
761
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$65,868
2023
$83,631
2022
$100,767
2021
$92,138
2020
$60,526
2019
$89,343
2018
$105,344
Payments by company (2024)
Janssen Biotech, Inc.
$25,319
Sumitomo Pharma America, Inc.
$9,702
Bayer Healthcare Pharmaceuticals Inc.
$9,333
SN Holdings, LLC
$4,795
Novartis Pharmaceuticals Corporation
$4,011
PFIZER INC.
$3,174
Ferring Pharmaceuticals Inc.
$2,205
Astellas Pharma Global Development
$1,755
UROGEN PHARMA, INC.
$1,594
Dendreon Pharmaceuticals LLC
$1,471
AstraZeneca Pharmaceuticals LP
$1,421
Telix Pharmaceuticals
$715
Astellas Pharma US Inc
$219
Janssen Scientific Affairs, LLC
$35
Myriad Genetic Laboratories, Inc.
$34
ABBVIE INC.
$25
Blue Earth Diagnostics Limited
$22
Tolmar, Inc.
$20
Axonics, Inc.
$19
Top 3 companies account for 67.3% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$132,433
Astellas Pharma US Inc
$84,925
Myovant Sciences Inc.
$67,589
Janssen Scientific Affairs, LLC
$49,428
SN Holdings, LLC
$39,023
Bayer HealthCare Pharmaceuticals Inc.
$32,167
Bayer Healthcare Pharmaceuticals Inc.
$30,825
UroGPO LLC
$25,645
Dendreon Pharmaceuticals LLC
$19,881
Sumitomo Pharma America, Inc.
$18,774
Progenics Pharmaceuticals, Inc.
$15,161
PFIZER INC.
$14,195
AstraZeneca Pharmaceuticals LP
$9,993
NOVARTIS PHARMACEUTICALS CORPORATION
$9,347
Astellas Pharma Global Development
$9,115
Sun Pharmaceutical Industries Inc.
$4,324
TOLMAR Pharmaceuticals, Inc.
$4,197
Novartis Pharmaceuticals Corporation
$4,037
UROGEN PHARMA, INC.
$3,994
Foundation Medicine, Inc.
$3,852
Clovis Oncology, Inc.
$3,145
Merck Sharp & Dohme Corporation
$3,074
Ferring Pharmaceuticals Inc.
$2,216
Amgen Inc.
$2,104
Exelixis Inc.
$1,980
Blue Earth Diagnostics Limited
$1,605
E.R. Squibb & Sons, L.L.C.
$850
Telix Pharmaceuticals
$794
ACCORD HEALTHCARE, INC.
$763
Verity Pharmaceuticals Inc.
$750
Merck Sharp & Dohme LLC
$181
Axonics, Inc.
$177
AbbVie, Inc.
$163
UroGen Pharma, Inc.
$138
Endo Pharmaceuticals Inc.
$102
Janssen Products, LP
$99
Allergan Inc.
$97
ABBVIE INC.
$70
GENZYME CORPORATION
$68
Tolmar, Inc.
$67
Mission Pharmacal Company
$50
UROVANT SCIENCES INC
$37
Antares Pharma, Inc.
$36
Myriad Genetic Laboratories, Inc.
$34
PROCEPT BioRobotics Corporation
$24
AbbVie Inc.
$21
Supernus Pharmaceuticals, Inc.
$19
Retrophin, Inc.
$17
Cook Medical LLC
$17
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AKEEGA · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CABOMETYX · CAMCEVI · Cook Medical Extractors · DARZALEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONACT · FOUNDATIONONE · FOUNDATIONONE CDX · GEMTESA · ILLUCCIX · IMFINZI · JELMYTO · JEVTANA · KEYTRUDA · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Natesto · Non-Covered · Nubeqa · ORGOVYX · Otrexup · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · RUBRACA · Rubraca · SUTENT · TLANDO · TOVIAZ · Trelstar · URIBEL · Uribel · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Surgerists in nearby ZIP areas
275
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Saltzstein is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Saltzstein experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Saltzstein performed 10,320 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Saltzstein receive payments from pharmaceutical companies?
Yes. Dr. Saltzstein received a total of $597,616 from 50 companies across 761 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saltzstein's costs compare to other surgerists in San Antonio?
Dr. Saltzstein's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saltzstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in San Antonio
Browse surgerists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in TX
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in TX
Which TX surgerists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Myovant Sciences Inc. Payments to Doctors
See all physicians who received payments from Myovant Sciences Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology